iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Aurobindo Pharma's WOS gets USFDA Approval for Medroxyprogesterone Acetate

24 Aug 2022 , 03:29 PM

Aurobindo Pharma Limited announced that Eugia Pharma Specialties Limited, its wholly owned subsidiary has received final FDA clearance to manufacture and commercialize Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL, 1 mL single dose Vial.

Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL, 1 mL Single-Dose Vial is bioequivalent and medically equivalent to Pfizer Inc.’s Depo-Provera Injectable Suspension.

The product will be available in the third quarter of FY23. According to IQVIA, the authorized product has a market size of roughly US$ 62 million for the period ending June 2022.

This is the 147 ANDA (including ten tentative approvals) received by Eugia Pharma Speciality Group (EPSG) facilities, which manufacture both oral and sterile specialty pharmaceuticals.

At around closing, Aurobindo Pharma was trading at Rs559.75 up by 0.03% from its previous closing of Rs559.60 on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Aurobindo Pharma News
  • Aurobindo Pharma Stocks
  • Aurobindo Pharma Updates
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.